• Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder

  • 2024/10/17
  • 再生時間： 5 分
  • ポッドキャスト

Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder.

    This Podcast is being Sponsored by LocumTenens.com
    続きを読む 一部表示

あらすじ・解説

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder.

This Podcast is being Sponsored by LocumTenens.com
続きを読む 一部表示

Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorderに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。